Suggested Topics within your search.
Suggested Topics within your search.
- Cancer 1
- Immune System 1
- Immunity 1
- Orthopedic surgery 1
- Orthopedics 1
- Pediatrics 1
- Tumors 1
-
3781
Timeline of cognitive impairments after radiotherapy for head and neck cancer: A review
Published 2025-05-01“…Background: With advances in cancer treatments, long-term impairments of survivors have become more apparent. Radiotherapy of tumors in or near the brain can potentially induce cognitive impairments, impacting the quality of life of survivors. …”
Get full text
Article -
3782
TNG908 is a brain-penetrant, MTA-cooperative PRMT5 inhibitor developed for the treatment of MTAP-deleted cancers
Published 2025-02-01“…TNG908 is being tested clinically in patients with MTAP-deleted tumors, including glioblastoma, in a Phase I/II clinical trial (NCT05275478).…”
Get full text
Article -
3783
Molecular Mechanism of Local Drug Delivery with Paclitaxel-Eluting Membranes in Biliary and Pancreatic Cancer: New Application for an Old Drug
Published 2015-01-01“…However, little is known about the molecular mechanisms by which paclitaxel-eluting stents attenuate tumor growth. We investigated the signal transduction pathways underlying the antiproliferative effects of a paclitaxel-eluting membrane (PEM) implanted in pancreatic/cholangiocarcinoma tumor bearing nude mice. …”
Get full text
Article -
3784
Genomic and phenotypic stability of fusion-driven pediatric sarcoma cell lines
Published 2025-01-01“…Additionally, the analysis of multiple EwS cell lines subjected to long-term continuous culture reveals that variable degrees of genomic/transcriptomic/phenotypic changes among fusion-driven cell lines, further exemplifying that the potential for reproducibility of in vitro scientific results may be rather understood as a spectrum, even within the same tumor entity.…”
Get full text
Article -
3785
Correlation between METTL3 overexpression and 18F-FDG uptake in patients with soft tissue sarcoma
Published 2025-01-01“…METTL3 expression in tumor and peritumoral tissues was evaluated with the Wilcoxon test. …”
Get full text
Article -
3786
First-in-human, multicenter, open-label, phase I study of ATOR-1017 (evunzekibart), a 4-1BB antibody, in patients with advanced solid malignancies
Published 2025-01-01“…ATOR-1017 activates T cells and natural killer cells in the tumor environment, leading to immune-mediated tumor cell death.Methods In this first-in-human, multicenter, phase I study, ATOR-1017 was administered intravenously every 21 days as a monotherapy to patients with advanced, unresectable solid tumors having received multiple standard-of-care treatments. …”
Get full text
Article -
3787
Paraplegia due to Thoracic Mobile Schwannoma after Myelography
Published 2020-01-01“…Introduction. Spinal mobile tumors are very rare. We herein report a case of paraplegia caused by migration and incarceration of thoracic mobile schwannoma after myelography. …”
Get full text
Article -
3788
GK-1 Improves the Immune Response Induced by Bone Marrow Dendritic Cells Loaded with MAGE-AX in Mice with Melanoma
Published 2014-01-01“…The aim of dendritic cell (DC) vaccination in cancer is to induce tumor-specific effector T cells that may reduce and control tumor mass. …”
Get full text
Article -
3789
High Prevalence of Human Papillomavirus in Colorectal Cancer in Hispanics: A Case-Control Study
Published 2016-01-01“…HPV-16 was detected in 63.2% of the HPV-positive colorectal tumors; genome integration was observed in all HPV-16 positive cases. …”
Get full text
Article -
3790
Clinical and molecular response to alpha1‐oleate treatment in patients with bladder cancer
Published 2024-09-01“…Uptake of alpha1‐oleate by the tumor triggered rapid shedding of tumor cells into the urine and cell death by an apoptosis‐like mechanism. …”
Get full text
Article -
3791
Low expression of TOX predicts poor prognosis of patients with breast cancer in the real world: A retrospective study
Published 2025-01-01“…Background: TOX is a transcription factor that is implicated in the regulation of T cell exhaustion in tumors. TOX has been proven to have prognostic value in some malignant tumors. …”
Get full text
Article -
3792
Establishment and characterization of a new mouse gastric carcinoma cell line, MCC
Published 2025-01-01“…This cell line demonstrated a 100% success rate in forming subcutaneous tumors in BALB/c mice. By integrating proteomic profiles from clinical gastric cancer patients and the murine subcutaneous tumor model, several molecular targets suitable for preclinical investigation were identified. …”
Get full text
Article -
3793
The diagnostic value of cytology in the mammary intraductal lesions of patients with pathological nipple discharge
Published 2025-01-01“…There were 22 breast malignant tumors, 75 intraductal papillomas and 22 non-tumorous lesions among the 119 PND patients. …”
Get full text
Article -
3794
Comparison of BCG Tokyo172 Strain Induction Therapy Between Low Dose and Standard Dose for Non-Muscle Invasive Bladder Cancer: Intravesical Instillation of BCG Tokyo172 Strain
Published 2025-01-01“…Results: The log-rank test showed that older age, low BCG dose, number of tumors, and a history of recurrence increased the risk of recurrence significantly. …”
Get full text
Article -
3795
Valproic acid targets IDH1 mutants through alteration of lipid metabolism
Published 2024-08-01“…In this study, we show that valproic acid (VPA), a brain penetrant anti-seizure medication and histone deacetylase inhibitor, inhibits the growth of IDH1 mutant tumors in vivo and in vitro, with at least some selectivity over IDH1 wild-type tumors. …”
Get full text
Article -
3796
Natural killer cells occupy unique spatial neighborhoods in HER2- and HER2+ human breast cancers
Published 2025-01-01“…As increasing evidence has demonstrated that the spatial organization of immune cells in tumor microenvironments is a significant parameter for impacting disease progression as well as therapeutic responses, an improved understanding of tumor-infiltrating NK cells and their location within tumor contextures is needed to improve the design of effective NK cell-based therapies. …”
Get full text
Article -
3797
A Giant Pedunculated Urothelial Polyp Mimicking Bladder Mass in a Child: A Rare Case
Published 2014-01-01“…Ureteral fibroepithelial polyps are rarely seen benign tumors with mesodermal origin. These polyps can involve kidney, pelvis, ureter, bladder, and urethra. …”
Get full text
Article -
3798
Mature Ovarian Teratoma: Neurological Implications in a Young Woman
Published 2021-01-01“…In some cases, it is associated with various tumors; one of them is ovarian teratoma, which mostly affects women below the age of 30 years. …”
Get full text
Article -
3799
To Live or to Die: Prosurvival Activity of PPARγ in Cancers
Published 2008-01-01“…We discuss the following five aspects of the nuclear hormone receptor and its agonists: (1) relative expression of PPARγ in human tumor versus normal tissues; (2) receptor-dependent proneoplastic effects; (3) impact of PPARγ and its agonists on tumors in animal models; (4) clinical trials of thiazolidinediones (TZDs) in human malignancies; (5) TZDs as chemopreventive agents in epidemiology studies. …”
Get full text
Article -
3800
A Giant Left Atrial Myxoma Neovascularized from the Right Coronary Artery
Published 2015-01-01“…Myxomas are benign and the most common tumors of the cardiac muscle (Reynen, 1995). They are predominantly located in the left atrium. …”
Get full text
Article